T0	Limitation 28661 28670	Estimated
T1	Limitation 31116 31119	The
T2	Limitation 31297 31301	This
T3	Limitation 31435 31443	Although
T4	Limitation 32300 32305	Study
T5	Limitation 32462 32475	Additionally,
T6	UnderpoweredStudy 31302 31319	small sample size
T7	CompositeIntervention 31332 31373	the heterogeneity of the study population
T8	NoPlaceboGroup 31507 31541	they received identical treatments
T9	UnderpoweredStudy 31155 31251	the small number of patients in each treatment group and the resultant lack of statistical power
T10	InappropriateFollowUpDuration 32300 32352	Study duration is another potential study limitation
T11	Generalization 32491 32677	all patients had previously been treated with, and failed to respond to, at least one TNF inhibitor, and thus, results seen here may not be directly applicable to the wider RA population
T12	UnderpoweredStudy 28789 28873	the study was not powered to show a statistical difference in the ACR response rates
